[Federal Register Volume 83, Number 30 (Tuesday, February 13, 2018)]
[Pages 6176-6177]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02826]



Centers for Disease Control and Prevention

Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of

[[Page 6177]]

the Director, Management Analysis and Services Office, CDC, pursuant to 
Public Law 92-463. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP); Funding Opportunity 
Announcement (FOA), IP18-001, Reducing Disparities in Vaccination 
Coverage by Poverty Status Among Young Children and IP18-003, 
Understanding and Addressing the Disparity in Vaccination Coverage 
Among U.S. Adolescents Living in Rural versus Urban Areas.
    Dates: March 20, 2018 and March 21, 2018.
    Time: 10:00 a.m.-5:00 p.m. (EDT)
    Place: Teleconference, Centers for Disease Control and 
Prevention, Room 1080, 8 Corporate, Atlanta, GA 30329.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E-60, 
Atlanta, Georgia 30333, (404) 718-8833, gca5@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-02826 Filed 2-12-18; 8:45 am]